During the past decade, Main Line Health Center-Exton conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Main Line Health Center-Exton" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Main Line Health Center-Exton" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Main Line Health Center-Exton" are "Invasive Breast Carcinoma" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials) and "Prognostic Stage II Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Main Line Health Center-Exton" in a lesser frequency.

Most popular intervention types in "Main Line Health Center-Exton" are "Drug" (28 trials), "Other" (19 trials), "Biological" (16 trials), "Procedure" (15 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (12 trials), "Quality-of-Life Assessment" (10 trials), "Biospecimen Collection" (9 trials), "Magnetic Resonance Imaging" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Main Line Health Center-Exton" are 28 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Main Line Health Center-Exton". undefined are not yet recruiting, 18 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Main Line Health Center-Exton, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Main Line Health Center-Exton, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".